share_log

Wells Fargo Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3

Wells Fargo Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3

富国银行假设Alaunos Therapeutics为增持,宣布目标价为3美元
Benzinga ·  2023/03/27 09:54

Wells Fargo analyst Yanan Zhu assumes Alaunos Therapeutics (NASDAQ:TCRT) with a Overweight rating and announces Price Target of $3.

富国银行分析师朱亚南假设Alaunos Therapeutics(纳斯达克股票代码:TCRT)的评级为增持,并宣布目标股价为3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发